Bluestar Adisseo Company, together with its subsidiaries, engages in the research, development, production, and sale of poultry, ruminant, swine, and aquaculture nutrition additives. The company also offers mycotoxin management and palatability comprising, Unike Plus, Unike, Oxy-Nil, Mold-Nil, Salmo-Nil, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, Delistart, Pepsea, Nutri-Bind Aqua, and Oxy-Nil Aqua Zero; enzymes and emulsifiers, including Rhodimet AT88 and Rhodimet; antioxidants and health by nutrition products, comprising Rhodimet AT88, Rhodimet NP99, Microvit A Supra 1000, and Microvit E Promix 50; milk production product, such as MetaSmart; and sulfur-based products, which includes Rhodimet AT88, Rhodimet® NP99, Microvit A Supra 1000, and Microvit E Promix 50. In addition, the company offers mycotoxin management products, such as Unike Plus, Unike, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, and Delistart, as well as essential nutrient products, such as Rhodimet AT88, a hydroxy-methionine in liquid form; and Microvit A Supra 1000 to deliver performance; Microvit E Promix 50, a specialized nutritional supplement of vitamin E; and AdiSodium, which helps monogastrics to livestock management. Further, it provides various services consisting of PNE, a near infra-red spectroscopy technology; MYCOMAN for the management of mycotoxins; ADICT, a nutritional values calculation tool; Predictor, a tool to help extract the value from feed; E.lab, a broad range of laboratory analyses to help feed and premix producers control the quality of raw materials and additives; DIM, a full support program; MilkPay calculator; Milk$MART; and NESTOR, which is used to formulate net energy. It operates in China, Europe, the Middle East, Africa, the Indian subcontinent, North and south America, the Asia-Pacific regions. The company was founded in 1939 and is based in Beijing, China. Bluestar Adisseo Company operates as a subsidiary of China National Bluestar (Group) Co,Ltd.
Metrics to compare | 600299 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600299PeersSector | |
|---|---|---|---|---|
P/E Ratio | 36.1x | 30.9x | 5.1x | |
PEG Ratio | −8.34 | 0.24 | 0.00 | |
Price/Book | 2.1x | 2.0x | 1.6x | |
Price / LTM Sales | 2.4x | 2.2x | 1.3x | |
Upside (Analyst Target) | −6.9% | 9.4% | 32.5% | |
Fair Value Upside | Unlock | 9.3% | 1.1% | Unlock |